Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.

However, the association between trial outcome and publication status did not reach statistical significance.

also in 111,027 other papers

In the sentence that followed, the above-mentioned p- value of 0.07 was reported and described as “marginally significant and favored ICH 204,636 [quetiapine].” Following that, four p- values above the 0.05 significance threshold were listed and described as “marginally significant.” The results of the completers analyses, described by the FDA as showing “no difference at all” (see above), were not reported in the journal article.

also in 26,082 other papers